Repare Therapeutics Announces US$82.5 Million Series B Financing

Sep 4, 2019 09:00 UTC CAMBRIDGE, Mass. & MONTREAL–(Business Wire)–Repare Therapeutics, a precision oncology company targeting specific vulnerabilities of tumors in genetically defined patient populations, announced today the completion of a US$82.5 million Series B financing. Cowen Healthcare Investments led the financing and was joined by new investors OrbiMed, […]

Leave a Reply